Antibodies (Mar 2024)

Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (<i>scFv</i>) Antibody Selection against Claudin 18.2 via Phage Display

  • Brian Effer,
  • Daniel Ulloa,
  • Camila Dappolonnio,
  • Francisca Muñoz,
  • Isabel Iturrieta-González,
  • Loraine Cotes,
  • Claudio Rojas,
  • Pamela Leal

DOI
https://doi.org/10.3390/antib13010020
Journal volume & issue
Vol. 13, no. 1
p. 20

Abstract

Read online

Gallbladder cancer (GBC) is a very aggressive malignant neoplasm of the biliary tract with a poor prognosis. There are no specific therapies for the treatment of GBC or early diagnosis tools; for this reason, the development of strategies and technologies that facilitate or allow an early diagnosis of GBC continues to be decisive. Phage display is a robust technique used for the production of monoclonal antibodies (mAbs) involving (1) the generation of gene libraries, (2) the screening and selection of isoforms related to an immobilized antigen, and (3) the in vitro maturation of the affinity of the antibody for the antigen. This research aimed to construct a human immune library from PBMCs of GBC patients and the isolation of scFv-phage clones with specificity against the larger extracellular loop belonging to claudin 18.2, which is an important biomarker overexpressed in GBC as well as gastric cancer. The immune-library-denominated GALLBLA1 was constructed from seven GBC patients and has a diversity of 6.12 × 1010 pfu mL−1. After three rounds of panning, we were able to identify clones with specificity against claudin 18.2. GALLBLA1 can contribute to the selection, isolation, and recombinant production of new human mAbs candidates for the treatment of gastrointestinal cancers.

Keywords